Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Anti-Tumor Drugs”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Post-approval studies (Phase 4)Study completedNCT02287350
What this trial is testing

Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain

Who this might be right for
Pain
Depomed 51
Testing effectiveness (Phase 2)UnknownNCT04472143
What this trial is testing

Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents

Who this might be right for
Chemotherapy-induced Nausea and Vomiting (CINV)
Fudan University 60
Testing effectiveness (Phase 2)Ended earlyNCT03992131
What this trial is testing

Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)

Who this might be right for
Ovarian CancerTriple-negative Breast CancerUrothelial Carcinoma+1 more
pharmaand GmbH 25
Large-scale testing (Phase 3)Study completedNCT00438087
What this trial is testing

Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery

Who this might be right for
Facial Palsy
Assistance Publique - Hôpitaux de Paris 313
Not applicableStudy completedNCT07305766
What this trial is testing

Construction and Preliminary Application of Evidence-Based Nursing Protocol for Oral Mucositis Related to Tumor Therapy

Who this might be right for
Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy
Peking Union Medical College 54
Not applicableUnknownNCT02875951
What this trial is testing

Investigating Patient Satisfaction With Oral Anti-cancer Treatment in Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer

Who this might be right for
ER Positive, HER2 Negative Breast Cancer Neoplasms
KU Leuven 100
Early research (Phase 1)Study completedNCT04179396
What this trial is testing

Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 8
Not applicableUnknownNCT04327583
What this trial is testing

Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy

Who this might be right for
Advanced or Metastatic Solid TumorRelapsed Hematologic Malignancy
Institut Cancerologie de l'Ouest 396
Early research (Phase 1)Looking for participantsNCT06717750
What this trial is testing

CSCJC3456 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. 102
Early research (Phase 1)Looking for participantsNCT04704661
What this trial is testing

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Who this might be right for
Advanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Ended earlyNCT00503776
What this trial is testing

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Who this might be right for
DysphagiaHead and Neck CancerMucositis+1 more
Vanderbilt-Ingram Cancer Center 41
Not applicableStudy completedNCT05299671
What this trial is testing

Video Consultation to Reduce Drug Interactions Among Patients Initiating Oral Anti-Cancer Drugs

Who this might be right for
Cancer
Columbia University 44
Early research (Phase 1)Not Yet RecruitingNCT07156227
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell Carcinoma+27 more
National Cancer Institute (NCI)
Not applicableEnded earlyNCT04595851
What this trial is testing

Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications

Who this might be right for
Chronic Myeloid LeukemiaChronic Lymphocytic LeukemiaMultiple Chronic Conditions
University of Michigan Rogel Cancer Center 6
Not applicableUnknownNCT03613389
What this trial is testing

Prevention of Oral Mucositis After Using Oral Topical Vitamin E Versus Voriconazole and Levofloxacin in Pediatric Cancer Patients Receiving Chemotherapy

Who this might be right for
Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy
Cairo University 15
Not applicableUnknownNCT05598788
What this trial is testing

Microsampling Approach for Monitoring of Kinase Inhibitor Targeted Therapies

Who this might be right for
Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib
Rennes University Hospital 360
Early research (Phase 1)Study completedNCT00264446
What this trial is testing

ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT02716116
What this trial is testing

TAK-788 in Adults With Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Takeda 334
Testing effectiveness (Phase 2)Active Not RecruitingNCT05172258
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+12 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00002188
What this trial is testing

ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Anderson Clinical Research 27
Load More Results
39
52